Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Safeguard Scientifics IncCommon Stock is an asset management business based in the US. Safeguard Scientifics IncCommon Stock shares (SFE) are listed on the NASDAQ and all prices are listed in US Dollars.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $3.22 |
|---|---|
| 52-week range | $2.85 - $6.41 |
| 50-day moving average | $3.13 |
| 200-day moving average | $3.72 |
| Wall St. target price | $16.00 |
| PE ratio | 22.1429 |
| Dividend yield | $0 (17.99%) |
| Earnings per share (TTM) | $0.14 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.22 from 2023-02-07
| 1 week (2023-02-02) | 1.26% |
|---|---|
| 1 month (2023-01-06) | 10.27% |
| 3 months (2022-11-07) | -6.70% |
| 6 months (2022-08-09) | -20.10% |
| 1 year (2022-02-09) | -48.89% |
|---|---|
| 2 years (2021-02-09) | -59.50% |
| 3 years (2020-02-07) | 10.22 |
| 5 years (2018-02-09) | 11.5647 |
Valuing Safeguard Scientifics IncCommon Stock stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Safeguard Scientifics IncCommon Stock's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Safeguard Scientifics IncCommon Stock's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Safeguard Scientifics IncCommon Stock shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -4.14% |
| Return on equity TTM | -26.1% |
| Profit margin | 0% |
| Book value | $2.46 |
| Market capitalisation | $50.6 million |
TTM: trailing 12 months
We're not expecting Safeguard Scientifics IncCommon Stock to pay a dividend over the next 12 months.
Safeguard Scientifics IncCommon Stock's shares were split on a 1:6 basis on 26 August 2009. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Safeguard Scientifics IncCommon Stock shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Safeguard Scientifics IncCommon Stock shares which in turn could have impacted Safeguard Scientifics IncCommon Stock's share price.
Over the last 12 months, Safeguard Scientifics IncCommon Stock's shares have ranged in value from as little as $2.85 up to $6.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Safeguard Scientifics IncCommon Stock's is 0.9407. This would suggest that Safeguard Scientifics IncCommon Stock's shares are less volatile than average (for this exchange).
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.